25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Genetic Technologies Ltd
Buy, Hold or Sell?

Let's analyze Genetic Technologies Ltd together

I guess you are interested in Genetic Technologies Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Genetic Technologies Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Genetic Technologies Ltd

I send you an email if I find something interesting about Genetic Technologies Ltd.

1. Quick Overview

1.1. Quick analysis of Genetic Technologies Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Genetic Technologies Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.02
Expected worth in 1 year
A$-0.36
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
A$-0.38
Return On Investment
-949.6%

For what price can you sell your share?

Current Price per Share
A$0.04
Expected price per share
A$0.039 - A$0.045
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Genetic Technologies Ltd (5 min.)




Live pricePrice per Share (EOD)
A$0.04
Intrinsic Value Per Share
A$-0.71 - A$-0.48
Total Value Per Share
A$-0.69 - A$-0.46

2.2. Growth of Genetic Technologies Ltd (5 min.)




Is Genetic Technologies Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$1.2m$7.5m-$6.3m-509.8%

How much money is Genetic Technologies Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$8.1m-$7.9m-$181k-2.2%
Net Profit Margin-156.8%-113.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Genetic Technologies Ltd (5 min.)




2.4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#116 / 138

Most Revenue
#103 / 138

Most Profit
#105 / 138

Most Efficient
#114 / 138
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Genetic Technologies Ltd?

Welcome investor! Genetic Technologies Ltd's management wants to use your money to grow the business. In return you get a share of Genetic Technologies Ltd.

First you should know what it really means to hold a share of Genetic Technologies Ltd. And how you can make/lose money.

Speculation

The Price per Share of Genetic Technologies Ltd is A$0.04. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Genetic Technologies Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Genetic Technologies Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.02. Based on the TTM, the Book Value Change Per Share is A$-0.09 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.05 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Genetic Technologies Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.07-169.1%-0.07-169.1%-0.08-197.0%-0.06-141.5%-0.05-133.9%
Usd Book Value Change Per Share-0.06-161.4%-0.06-161.4%-0.04-89.2%0.00-0.8%0.00-0.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.06-161.4%-0.06-161.4%-0.04-89.2%0.00-0.8%0.00-0.5%
Usd Price Per Share0.05-0.05-0.00-0.01-0.01-
Price to Earnings Ratio-0.75--0.75--0.02--0.20--0.19-
Price-to-Total Gains Ratio-0.79--0.79--0.05--0.15--0.18-
Price to Book Ratio4.95-4.95-0.02-1.01-0.60-
Price-to-Total Gains Ratio-0.79--0.79--0.05--0.15--0.18-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.027196
Number of shares36770
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.060.00
Usd Total Gains Per Share-0.060.00
Gains per Quarter (36770 shares)-2,373.87-11.88
Gains per Year (36770 shares)-9,495.49-47.51
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-9495-95050-48-58
20-18991-190000-95-106
30-28486-284950-143-154
40-37982-379900-190-202
50-47477-474850-238-250
60-56973-569800-285-298
70-66468-664750-333-346
80-75964-759700-380-394
90-85459-854650-428-442
100-94955-949600-475-490

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%1.024.00.04.0%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%2.03.00.040.0%3.07.00.030.0%10.015.00.040.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.025.00.0%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%2.03.00.040.0%3.07.00.030.0%10.015.00.040.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Genetic Technologies Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.095-0.0950%-0.052-45%0.000-99%0.000-100%
Book Value Per Share--0.0150.0150%0.110-86%0.128-88%0.111-86%
Current Ratio--0.8810.8810%3.170-72%6.921-87%6.919-87%
Debt To Asset Ratio--0.7040.7040%0.249+183%0.266+165%0.234+201%
Debt To Equity Ratio--2.3802.3800%0.331+619%0.632+276%0.467+410%
Dividend Per Share----0%-0%-0%-0%
Eps---0.099-0.0990%-0.116+17%-0.083-16%-0.079-21%
Free Cash Flow Per Share---0.079-0.0790%-0.096+21%-0.072-10%-0.072-9%
Free Cash Flow To Equity Per Share---0.056-0.0560%-0.038-32%0.008-782%0.000-11396%
Gross Profit Margin--1.0001.0000%1.251-20%1.156-13%1.227-18%
Intrinsic Value_10Y_max---0.476--------
Intrinsic Value_10Y_min---0.708--------
Intrinsic Value_1Y_max---0.067--------
Intrinsic Value_1Y_min---0.077--------
Intrinsic Value_3Y_max---0.186--------
Intrinsic Value_3Y_min---0.226--------
Intrinsic Value_5Y_max---0.287--------
Intrinsic Value_5Y_min---0.371--------
Market Cap4042560.000-124%9061308.9009061308.9000%253451.875+3475%2196463.355+313%1805679.678+402%
Net Profit Margin---1.568-1.5680%-1.136-28%-136.153+8584%-100.903+6336%
Operating Margin---1.641-1.6410%-1.035-37%-136.533+8218%-98.320+5890%
Operating Ratio--2.6412.6410%2.169+22%140.697-98%101.022-97%
Pb Ratio2.640-88%4.9504.9500%0.023+21703%1.014+388%0.600+725%
Pe Ratio-0.402+47%-0.754-0.7540%-0.022-97%-0.204-73%-0.193-74%
Price Per Share0.040-88%0.0750.0750%0.003+2900%0.019+299%0.016+357%
Price To Free Cash Flow Ratio-0.505+47%-0.947-0.9470%-0.026-97%-0.247-74%-0.214-77%
Price To Total Gains Ratio-0.421+47%-0.790-0.7900%-0.048-94%-0.148-81%-0.177-78%
Quick Ratio--0.7500.7500%2.439-69%6.549-89%6.526-89%
Return On Assets---1.942-1.9420%-0.791-59%-0.755-61%-0.851-56%
Return On Equity---6.565-6.5650%-1.053-84%-1.763-73%-1.580-76%
Total Gains Per Share---0.095-0.0950%-0.052-45%0.000-99%0.000-100%
Usd Book Value--1244499.1591244499.1590%7589435.422-84%8831860.750-86%7672961.749-84%
Usd Book Value Change Per Share---0.065-0.0650%-0.036-45%0.000-99%0.000-100%
Usd Book Value Per Share--0.0100.0100%0.075-86%0.087-88%0.076-86%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.068-0.0680%-0.079+17%-0.057-16%-0.054-21%
Usd Free Cash Flow---6507319.501-6507319.5010%-6622665.895+2%-5134063.464-21%-5063982.635-22%
Usd Free Cash Flow Per Share---0.054-0.0540%-0.065+21%-0.049-10%-0.049-9%
Usd Free Cash Flow To Equity Per Share---0.038-0.0380%-0.026-32%0.006-782%0.000-11396%
Usd Market Cap2748536.544-124%6160783.9216160783.9210%172321.930+3475%1493375.435+313%1227681.613+402%
Usd Price Per Share0.027-88%0.0510.0510%0.002+2900%0.013+299%0.011+357%
Usd Profit---8170507.198-8170507.1980%-7989452.548-2%-5993412.190-27%-5578280.888-32%
Usd Revenue--5211286.6425211286.6420%7035541.289-26%3391058.906+54%1938233.900+169%
Usd Total Gains Per Share---0.065-0.0650%-0.036-45%0.000-99%0.000-100%
 EOD+3 -5MRQTTM+0 -0YOY+10 -245Y+9 -2510Y+9 -25

3.3 Fundamental Score

Let's check the fundamental score of Genetic Technologies Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.402
Price to Book Ratio (EOD)Between0-12.640
Net Profit Margin (MRQ)Greater than0-1.568
Operating Margin (MRQ)Greater than0-1.641
Quick Ratio (MRQ)Greater than10.750
Current Ratio (MRQ)Greater than10.881
Debt to Asset Ratio (MRQ)Less than10.704
Debt to Equity Ratio (MRQ)Less than12.380
Return on Equity (MRQ)Greater than0.15-6.565
Return on Assets (MRQ)Greater than0.05-1.942
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Genetic Technologies Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.375
Ma 20Greater thanMa 500.040
Ma 50Greater thanMa 1000.041
Ma 100Greater thanMa 2000.062
OpenGreater thanClose0.043
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Genetic Technologies Ltd

Genetic Technologies Limited, a molecular diagnostics company, provides predictive genetic testing and risk assessment tools to help physicians manage people's health in the America, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. It operates through AffinityDNA, EasyDNA, and GeneType/Corporate segments. The company offers BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, the company offers various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer brand names; and develops other risk assessment tests across a range of diseases, which include colorectal cancer, ovarian cancer, prostate cancer, coronary artery, type 2 diabetes, pancreatic cancer, melanoma, and atrial fibrillation. Further, it offers genetic testing services, including medical, animal, forensic, and plant testing. The company has research and collaboration agreements with the University of Melbourne for the development and commercialization of a novel colorectal cancer risk assessment test; and Memorial Sloan Kettering Cancer Center of New York and University of Cambridge, that assess the conflict among BRCA mutation carriers considering preventive surgery. Genetic Technologies Limited was incorporated in 1987 and is headquartered in Fitzroy, Australia.

Fundamental data was last updated by Penke on 2024-09-22 10:07:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Genetic Technologies Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Genetic Technologies Ltd to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -156.8% means that $-1.57 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Genetic Technologies Ltd:

  • The MRQ is -156.8%. The company is making a huge loss. -2
  • The TTM is -156.8%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-156.8%TTM-156.8%0.0%
TTM-156.8%YOY-113.6%-43.2%
TTM-156.8%5Y-13,615.3%+13,458.5%
5Y-13,615.3%10Y-10,090.3%-3,524.9%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-156.8%-2.3%-154.5%
TTM-156.8%-7.1%-149.7%
YOY-113.6%-5.1%-108.5%
5Y-13,615.3%-2.8%-13,612.5%
10Y-10,090.3%-0.3%-10,090.0%
4.3.1.2. Return on Assets

Shows how efficient Genetic Technologies Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Genetic Technologies Ltd to the Diagnostics & Research industry mean.
  • -194.2% Return on Assets means that Genetic Technologies Ltd generated $-1.94 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Genetic Technologies Ltd:

  • The MRQ is -194.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -194.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-194.2%TTM-194.2%0.0%
TTM-194.2%YOY-79.1%-115.2%
TTM-194.2%5Y-75.5%-118.8%
5Y-75.5%10Y-85.1%+9.6%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-194.2%-0.9%-193.3%
TTM-194.2%-1.3%-192.9%
YOY-79.1%-1.4%-77.7%
5Y-75.5%-0.4%-75.1%
10Y-85.1%-0.5%-84.6%
4.3.1.3. Return on Equity

Shows how efficient Genetic Technologies Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Genetic Technologies Ltd to the Diagnostics & Research industry mean.
  • -656.5% Return on Equity means Genetic Technologies Ltd generated $-6.57 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Genetic Technologies Ltd:

  • The MRQ is -656.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -656.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-656.5%TTM-656.5%0.0%
TTM-656.5%YOY-105.3%-551.3%
TTM-656.5%5Y-176.3%-480.2%
5Y-176.3%10Y-158.0%-18.3%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-656.5%-0.3%-656.2%
TTM-656.5%-0.5%-656.0%
YOY-105.3%-0.1%-105.2%
5Y-176.3%-1.0%-175.3%
10Y-158.0%-1.6%-156.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Genetic Technologies Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Genetic Technologies Ltd is operating .

  • Measures how much profit Genetic Technologies Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Genetic Technologies Ltd to the Diagnostics & Research industry mean.
  • An Operating Margin of -164.1% means the company generated $-1.64  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Genetic Technologies Ltd:

  • The MRQ is -164.1%. The company is operating very inefficient. -2
  • The TTM is -164.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-164.1%TTM-164.1%0.0%
TTM-164.1%YOY-103.5%-60.6%
TTM-164.1%5Y-13,653.3%+13,489.2%
5Y-13,653.3%10Y-9,832.0%-3,821.3%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-164.1%-14.4%-149.7%
TTM-164.1%-13.2%-150.9%
YOY-103.5%1.7%-105.2%
5Y-13,653.3%1.4%-13,654.7%
10Y-9,832.0%3.6%-9,835.6%
4.3.2.2. Operating Ratio

Measures how efficient Genetic Technologies Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 2.64 means that the operating costs are $2.64 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Genetic Technologies Ltd:

  • The MRQ is 2.641. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.641. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.641TTM2.6410.000
TTM2.641YOY2.169+0.472
TTM2.6415Y140.697-138.055
5Y140.69710Y101.022+39.675
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6411.323+1.318
TTM2.6411.311+1.330
YOY2.1691.304+0.865
5Y140.6971.274+139.423
10Y101.0221.192+99.830
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Genetic Technologies Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Genetic Technologies Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 0.88 means the company has $0.88 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Genetic Technologies Ltd:

  • The MRQ is 0.881. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.881. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.881TTM0.8810.000
TTM0.881YOY3.170-2.289
TTM0.8815Y6.921-6.040
5Y6.92110Y6.919+0.001
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8812.012-1.131
TTM0.8812.112-1.231
YOY3.1702.563+0.607
5Y6.9212.646+4.275
10Y6.9193.202+3.717
4.4.3.2. Quick Ratio

Measures if Genetic Technologies Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Genetic Technologies Ltd to the Diagnostics & Research industry mean.
  • A Quick Ratio of 0.75 means the company can pay off $0.75 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Genetic Technologies Ltd:

  • The MRQ is 0.750. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.750. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.750TTM0.7500.000
TTM0.750YOY2.439-1.689
TTM0.7505Y6.549-5.799
5Y6.54910Y6.526+0.023
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7501.194-0.444
TTM0.7501.238-0.488
YOY2.4391.684+0.755
5Y6.5492.000+4.549
10Y6.5262.360+4.166
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Genetic Technologies Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Genetic Technologies Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Genetic Technologies Ltd to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.70 means that Genetic Technologies Ltd assets are financed with 70.4% credit (debt) and the remaining percentage (100% - 70.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Genetic Technologies Ltd:

  • The MRQ is 0.704. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.704. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.704TTM0.7040.000
TTM0.704YOY0.249+0.456
TTM0.7045Y0.266+0.438
5Y0.26610Y0.234+0.032
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7040.442+0.262
TTM0.7040.439+0.265
YOY0.2490.360-0.111
5Y0.2660.425-0.159
10Y0.2340.450-0.216
4.5.4.2. Debt to Equity Ratio

Measures if Genetic Technologies Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Genetic Technologies Ltd to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 238.0% means that company has $2.38 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Genetic Technologies Ltd:

  • The MRQ is 2.380. The company is just not able to pay all its debts with equity.
  • The TTM is 2.380. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.380TTM2.3800.000
TTM2.380YOY0.331+2.049
TTM2.3805Y0.632+1.748
5Y0.63210Y0.467+0.165
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3800.642+1.738
TTM2.3800.669+1.711
YOY0.3310.527-0.196
5Y0.6320.666-0.034
10Y0.4670.736-0.269
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Genetic Technologies Ltd generates.

  • Above 15 is considered overpriced but always compare Genetic Technologies Ltd to the Diagnostics & Research industry mean.
  • A PE ratio of -0.75 means the investor is paying $-0.75 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Genetic Technologies Ltd:

  • The EOD is -0.402. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.754. Based on the earnings, the company is expensive. -2
  • The TTM is -0.754. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.402MRQ-0.754+0.352
MRQ-0.754TTM-0.7540.000
TTM-0.754YOY-0.022-0.732
TTM-0.7545Y-0.204-0.550
5Y-0.20410Y-0.193-0.011
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-0.402-0.362-0.040
MRQ-0.754-0.693-0.061
TTM-0.754-0.693-0.061
YOY-0.022-0.088+0.066
5Y-0.2041.735-1.939
10Y-0.1933.677-3.870
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Genetic Technologies Ltd:

  • The EOD is -0.505. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.947. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.947. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.505MRQ-0.947+0.442
MRQ-0.947TTM-0.9470.000
TTM-0.947YOY-0.026-0.921
TTM-0.9475Y-0.247-0.699
5Y-0.24710Y-0.214-0.033
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-0.505-0.624+0.119
MRQ-0.947-1.060+0.113
TTM-0.947-1.065+0.118
YOY-0.026-3.226+3.200
5Y-0.247-1.609+1.362
10Y-0.214-2.309+2.095
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Genetic Technologies Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 4.95 means the investor is paying $4.95 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Genetic Technologies Ltd:

  • The EOD is 2.640. Based on the equity, the company is underpriced. +1
  • The MRQ is 4.950. Based on the equity, the company is fair priced.
  • The TTM is 4.950. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.640MRQ4.950-2.310
MRQ4.950TTM4.9500.000
TTM4.950YOY0.023+4.928
TTM4.9505Y1.014+3.937
5Y1.01410Y0.600+0.413
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD2.6402.299+0.341
MRQ4.9502.090+2.860
TTM4.9502.172+2.778
YOY0.0232.396-2.373
5Y1.0143.746-2.732
10Y0.6004.171-3.571
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Genetic Technologies Ltd.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-06-302021-06-302022-06-302023-06-302024-06-30
Long-term Assets Other  -440-9,100-9,5403,455-6,0851,848-4,2374,597360
Net Working Capital  13,7957,03620,831-9,92610,905-3,7197,186-7,686-500



5.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. All numbers in thousands.

Summary
Total Assets6,187
Total Liabilities4,356
Total Stockholder Equity1,830
 As reported
Total Liabilities 4,356
Total Stockholder Equity+ 1,830
Total Assets = 6,187

Assets

Total Assets6,187
Total Current Assets3,695
Long-term Assets2,491
Total Current Assets
Cash And Cash Equivalents 1,021
Net Receivables 2,127
Inventory 206
Other Current Assets 342
Total Current Assets  (as reported)3,695
Total Current Assets  (calculated)3,695
+/-0
Long-term Assets
Property Plant Equipment 264
Goodwill 1,785
Long-term Assets Other 360
Long-term Assets  (as reported)2,491
Long-term Assets  (calculated)2,409
+/- 82

Liabilities & Shareholders' Equity

Total Current Liabilities4,195
Long-term Liabilities161
Total Stockholder Equity1,830
Total Current Liabilities
Short-term Debt 852
Accounts payable 1,458
Other Current Liabilities 1,143
Total Current Liabilities  (as reported)4,195
Total Current Liabilities  (calculated)3,454
+/- 742
Long-term Liabilities
Long-term Liabilities  (as reported)161
Long-term Liabilities  (calculated)0
+/- 161
Total Stockholder Equity
Common Stock163,818
Retained Earnings -166,376
Accumulated Other Comprehensive Income 4,389
Total Stockholder Equity (as reported)1,830
Total Stockholder Equity (calculated)1,830
+/-0
Other
Cash and Short Term Investments 1,021
Common Stock Shares Outstanding 120,817
Current Deferred Revenue742
Liabilities and Stockholders Equity 6,187
Net Debt -145
Net Working Capital -500
Short Long Term Debt Total 875



5.3. Balance Sheets Structured

All numbers in thousands.

 Trend2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-30
> Total Assets 
8,847
39,686
33,001
30,245
22,389
29,264
22,442
20,952
24,146
22,276
8,280
8,922
16,442
8,320
6,729
20,720
13,290
12,108
6,166
3,265
15,633
22,972
20,802
14,856
6,187
6,18714,85620,80222,97215,6333,2656,16612,10813,29020,7206,7298,32016,4428,9228,28022,27624,14620,95222,44229,26422,38930,24533,00139,6868,847
   > Total Current Assets 
5,402
3,382
8,245
7,373
12,964
19,675
13,092
13,651
15,928
12,519
4,502
6,255
9,950
2,657
4,361
19,566
12,131
11,632
5,991
3,196
15,193
22,236
14,717
10,498
3,695
3,69510,49814,71722,23615,1933,1965,99111,63212,13119,5664,3612,6579,9506,2554,50212,51915,92813,65113,09219,67512,9647,3738,2453,3825,402
       Cash And Cash Equivalents 
1,229
646
7,160
5,829
11,299
17,658
11,102
12,460
12,949
9,698
3,306
5,105
8,900
1,721
2,831
18,341
11,180
10,988
5,487
2,132
14,214
20,902
11,731
7,851
1,021
1,0217,85111,73120,90214,2142,1325,48710,98811,18018,3412,8311,7218,9005,1053,3069,69812,94912,46011,10217,65811,2995,8297,1606461,229
       Short-term Investments 
0
0
70
262
38
88
0
77
519
0
72
3
17
209
3
4
4
3
4
53
2
2
13
17
0
0171322534344320917372051977088382627000
       Net Receivables 
89
191
233
1,237
1,627
1,191
1,401
647
1,600
2,267
755
674
496
329
895
525
393
201
11
17
39
1,074
2,421
192
2,127
2,1271922,4211,0743917112013935258953294966747552,2671,6006471,4011,1911,6271,23723319189
       Inventory 
4,083
2,458
782
258
0
0
588
544
859
554
298
474
317
214
213
317
167
77
59
32
91
77
398
326
206
2063263987791325977167317213214317474298554859544588002587822,4584,083
   > Long-term Assets 
3,445
36,304
24,756
22,872
9,425
9,589
9,350
7,301
8,218
9,757
3,777
2,667
6,492
5,662
1,573
1,154
1,159
477
175
69
440
736
6,085
4,237
2,491
2,4914,2376,085736440691754771,1591,1541,5735,6626,4922,6673,7779,7578,2187,3019,3509,5899,42522,87224,75636,3043,445
       Property Plant Equipment 
334
801
492
1,490
1,841
2,604
2,267
1,946
1,707
3,730
1,978
948
643
423
394
418
550
477
175
69
440
638
953
599
264
264599953638440691754775504183944236439481,9783,7301,7071,9462,2672,6041,8411,490492801334
       Goodwill 
0
24,509
405
453
413
455
346
346
316
1,582
318
315
315
315
315
0
0
0
0
0
0
4,507
4,507
3,117
1,785
1,7853,1174,5074,5070000003153153153153181,58231634634645541345340524,5090
       Intangible Assets 
0
27,364
23,985
20,179
6,862
6,246
5,148
3,349
5,987
5,712
1,482
1,404
1,119
991
864
736
608
0
0
0
0
5,132
625
520
0
05206255,13200006087368649911,1191,4041,4825,7125,9873,3495,1486,2466,86220,17923,98527,3640
       Long-term Assets Other 
3,112
8,140
279
750
722
740
1,589
1,658
208
-1,102
0
0
0
-5,662
-1,573
-1,154
-1,159
-477
-2,500
-69
-440
-9,540
-6,085
-4,237
360
360-4,237-6,085-9,540-440-69-2,500-477-1,159-1,154-1,573-5,662000-1,1022081,6581,5897407227502798,1403,112
> Total Liabilities 
1,270
1,618
1,865
2,968
5,321
6,510
4,176
4,051
3,317
4,790
2,562
2,108
2,039
2,561
4,902
1,760
1,406
1,529
1,454
1,494
1,640
1,439
4,371
3,694
4,356
4,3563,6944,3711,4391,6401,4941,4541,5291,4061,7604,9022,5612,0392,1082,5624,7903,3174,0514,1766,5105,3212,9681,8651,6181,270
   > Total Current Liabilities 
1,270
1,618
1,865
2,968
4,624
4,903
2,947
3,252
3,054
4,683
2,479
2,026
1,931
2,465
2,318
1,735
1,332
1,465
1,451
1,493
1,398
1,405
3,812
3,312
4,195
4,1953,3123,8121,4051,3981,4931,4511,4651,3321,7352,3182,4651,9312,0262,4794,6833,0543,2522,9474,9034,6242,9681,8651,6181,270
       Short-term Debt 
0
120
0
0
0
435
491
478
111
463
383
68
18
209
153
25
4
3
4
241
241
180
264
304
852
8523042641802412414342515320918683834631114784914350001200
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,502
25
0
0
0
0
0
0
0
0
0
000000000252,50200000000000000
       Accounts payable 
385
446
717
1,379
2,004
3,002
1,411
1,565
1,790
2,675
1,196
1,115
906
622
900
517
392
398
536
590
350
270
1,154
838
1,458
1,4588381,1542703505905363983925179006229061,1151,1962,6751,7901,5651,4113,0022,0041,379717446385
       Other Current Liabilities 
1,270
1,498
1,865
1,589
1,958
985
1,012
888
1,013
1,262
706
679
740
1,522
1,418
1,116
940
1,067
915
903
1,047
955
1,580
1,321
1,143
1,1431,3211,5809551,0479039151,0679401,1161,4181,5227406797061,2621,0138881,0129851,9581,5891,8651,4981,270
   > Long-term Liabilities 
0
0
0
697
696
1,607
1,229
798
263
107
83
83
109
96
2,502
25
74
64
2,503
1
52
33
559
382
161
161382559335212,5036474252,5029610983831072637981,2291,607696697000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
241
24
388
229
0
02293882424100000000000000000000
       Other Liabilities 
0
0
0
0
0
0
37
50
75
86
83
83
109
96
81
25
74
64
3
1
979
9
171
152
0
01521719979136474258196109838386755037000000
> Total Stockholder Equity
7,577
38,068
31,136
27,277
16,951
22,590
18,091
16,756
20,688
17,294
5,533
6,612
14,248
5,638
1,828
18,959
11,883
10,579
4,712
1,771
13,993
21,533
16,431
11,163
1,830
1,83011,16316,43121,53313,9931,7714,71210,57911,88318,9591,8285,63814,2486,6125,53317,29420,68816,75618,09122,59016,95127,27731,13638,0687,577
   Common Stock
20,212
53,957
39,351
39,684
24,732
36,164
37,993
70,244
70,244
88,329
72,378
72,378
83,280
83,736
90,080
115,247
115,273
122,383
122,373
125,499
140,111
153,575
155,139
161,343
163,818
163,818161,343155,139153,575140,111125,499122,373122,383115,273115,24790,08083,73683,28072,37872,37888,32970,24470,24437,99336,16424,73239,68439,35153,95720,212
   Retained Earnings -166,376-156,716-150,206-143,075-136,047-129,738-123,312-117,848-109,444-100,985-92,175-82,050-72,752-67,464-66,845-71,034-51,299-21,712-22,913-17,026-10,354-12,293-8,243-17,907-14,517
   Capital Surplus 0000000000000000000000000
   Treasury Stock0000000000000000000000000
   Other Stockholders Equity 
1,882
2,018
28
-1,467
0
0
0
33,686
151
5,638
1,378
7,269
0
0
3,922
4,697
1,420
6,044
5,651
6,010
1,173
-10,500
-4,932
-4,627
0
0-4,627-4,932-10,5001,1736,0105,6516,0441,4204,6973,922007,2691,3785,63815133,686000-1,467282,0181,882



5.4. Balance Sheets

All numbers in thousands.




5.5. Cash Flows

All numbers in thousands.




5.6. Income Statements

All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-06-30. All numbers in thousands.

Gross Profit (+$)
totalRevenue7,665
Cost of Revenue-11,974
Gross Profit-4,309-4,309
 
Operating Income (+$)
Gross Profit-4,309
Operating Expense-8,272
Operating Income-12,581-12,581
 
Operating Expense (+$)
Research Development753
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense8,272753
 
Net Interest Income (+$)
Interest Income0
Interest Expense-52
Other Finance Cost-52
Net Interest Income0
 
Pretax Income (+$)
Operating Income-12,581
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-14,004-11,158
EBIT - interestExpense = -12,633
-14,004
-11,966
Interest Expense52
Earnings Before Interest and Taxes (EBIT)-12,581-13,953
Earnings Before Interest and Taxes (EBITDA)-12,046
 
After tax Income (+$)
Income Before Tax-14,004
Tax Provision-0
Net Income From Continuing Ops0-14,004
Net Income-12,017
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses20,246
Total Other Income/Expenses Net-1,4230
 

Technical Analysis of Genetic Technologies Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Genetic Technologies Ltd. The general trend of Genetic Technologies Ltd is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Genetic Technologies Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Genetic Technologies Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.043 < 0.045 < 0.045.

The bearish price targets are: 0.042 > 0.042 > 0.039.

Tweet this
Genetic Technologies Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Genetic Technologies Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Genetic Technologies Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Genetic Technologies Ltd. The current macd is -0.00073126.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Genetic Technologies Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Genetic Technologies Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Genetic Technologies Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Genetic Technologies Ltd Daily Moving Average Convergence/Divergence (MACD) ChartGenetic Technologies Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Genetic Technologies Ltd. The current adx is 17.37.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Genetic Technologies Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Genetic Technologies Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Genetic Technologies Ltd. The current sar is 0.0381.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Genetic Technologies Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Genetic Technologies Ltd. The current rsi is 47.37. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Genetic Technologies Ltd Daily Relative Strength Index (RSI) ChartGenetic Technologies Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Genetic Technologies Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Genetic Technologies Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Genetic Technologies Ltd Daily Stochastic Oscillator ChartGenetic Technologies Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Genetic Technologies Ltd. The current cci is 54.05.

Genetic Technologies Ltd Daily Commodity Channel Index (CCI) ChartGenetic Technologies Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Genetic Technologies Ltd. The current cmo is -3.11771184.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Genetic Technologies Ltd Daily Chande Momentum Oscillator (CMO) ChartGenetic Technologies Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Genetic Technologies Ltd. The current willr is -60.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Genetic Technologies Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Genetic Technologies Ltd Daily Williams %R ChartGenetic Technologies Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Genetic Technologies Ltd.

Genetic Technologies Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Genetic Technologies Ltd. The current atr is 0.00209262.

Genetic Technologies Ltd Daily Average True Range (ATR) ChartGenetic Technologies Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Genetic Technologies Ltd. The current obv is -7,371,740.

Genetic Technologies Ltd Daily On-Balance Volume (OBV) ChartGenetic Technologies Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Genetic Technologies Ltd. The current mfi is 46.15.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Genetic Technologies Ltd Daily Money Flow Index (MFI) ChartGenetic Technologies Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Genetic Technologies Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-05-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-05-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-05-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-19MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-06-20STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-06-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-06-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-07-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-07-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-31SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-05MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-14MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-10-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Genetic Technologies Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Genetic Technologies Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.375
Ma 20Greater thanMa 500.040
Ma 50Greater thanMa 1000.041
Ma 100Greater thanMa 2000.062
OpenGreater thanClose0.043
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Genetic Technologies Ltd with someone you think should read this too:
  • Are you bullish or bearish on Genetic Technologies Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Genetic Technologies Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Genetic Technologies Ltd

I send you an email if I find something interesting about Genetic Technologies Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Genetic Technologies Ltd.

Receive notifications about Genetic Technologies Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.